LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 7282

Search options

  1. Article ; Online: Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.

    Nementzik, Laura R / Thumbadoo, Kyrah M / Murray, Helen C / Gordon, David / Yang, Shu / Blair, Ian P / Turner, Clinton / Faull, Richard L M / Curtis, Maurice A / McLean, Catriona / Nicholson, Garth A / Swanson, Molly E V / Scotter, Emma L

    Brain pathology (Zurich, Switzerland)

    2023  Volume 34, Issue 3, Page(s) e13230

    Abstract: ... UBQLN2 p.T487I-linked ALS/FTD cases, three non-UBQLN2-linked (sporadic) ALS cases, and 8 non ...

    Abstract Mutations in the UBQLN2 gene cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The neuropathology of such UBQLN2-linked cases of ALS/FTD is characterised by aggregates of the ubiquilin 2 protein in addition to aggregates of the transactive response DNA-binding protein of 43 kDa (TDP-43). ALS and FTD without UBQLN2 mutations are also characterised by TDP-43 aggregates, that may or may not colocalise with wildtype ubiquilin 2. Despite this, the relative contributions of TDP-43 and ubiquilin 2 to disease pathogenesis remain largely under-characterised, as does their relative deposition as aggregates across the central nervous system (CNS). Here we conducted multiplex immunohistochemistry of three UBQLN2 p.T487I-linked ALS/FTD cases, three non-UBQLN2-linked (sporadic) ALS cases, and 8 non-neurodegenerative disease controls, covering 40 CNS regions. We then quantified ubiquilin 2 aggregates, TDP-43 aggregates and aggregates containing both proteins in regions of interest to determine how UBQLN2-linked and non-UBQLN2-linked proteinopathy differ. We find that ubiquilin 2 aggregates that are negative for TDP-43 are predominantly small and punctate and are abundant in the hippocampal formation, spinal cord, all tested regions of neocortex, medulla and substantia nigra in UBQLN2-linked ALS/FTD but not sporadic ALS. Curiously, the striatum harboured small punctate ubiquilin 2 aggregates in all cases examined, while large diffuse striatal ubiquilin 2 aggregates were specific to UBQLN2-linked ALS/FTD. Overall, ubiquilin 2 is mainly deposited in clinically unaffected regions throughout the CNS such that symptomology in UBQLN2-linked cases maps best to the aggregation of TDP-43.
    MeSH term(s) Humans ; Adaptor Proteins, Signal Transducing/metabolism ; Amyotrophic Lateral Sclerosis/pathology ; Autophagy-Related Proteins/metabolism ; DNA-Binding Proteins/metabolism ; Frontotemporal Dementia/genetics ; Frontotemporal Dementia/metabolism ; Mutation ; Transcription Factors/metabolism
    Chemical Substances Adaptor Proteins, Signal Transducing ; Autophagy-Related Proteins ; DNA-Binding Proteins ; Transcription Factors ; UBQLN2 protein, human ; TARDBP protein, human
    Language English
    Publishing date 2023-12-19
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1051484-3
    ISSN 1750-3639 ; 1015-6305
    ISSN (online) 1750-3639
    ISSN 1015-6305
    DOI 10.1111/bpa.13230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A hydrogen-driven biocatalytic approach to recycling synthetic analogues of NAD(P)H.

    Reeve, Holly A / Nicholson, Jake / Altaf, Farieha / Lonsdale, Thomas H / Preissler, Janina / Lauterbach, Lars / Lenz, Oliver / Leimkühler, Silke / Hollmann, Frank / Paul, Caroline E / Vincent, Kylie A

    Chemical communications (Cambridge, England)

    2022  Volume 58, Issue 75, Page(s) 10540–10543

    Abstract: We demonstrate a recycling system for synthetic nicotinamide cofactor analogues using a soluble hydrogenase with turnover number of >1000 for reduction of the cofactor analogues by ... ...

    Abstract We demonstrate a recycling system for synthetic nicotinamide cofactor analogues using a soluble hydrogenase with turnover number of >1000 for reduction of the cofactor analogues by H
    MeSH term(s) Ethylmaleimide ; Hydrogen ; Hydrogenase/metabolism ; NAD/metabolism ; Niacinamide ; Oxidation-Reduction ; Oxidoreductases/metabolism ; Succinimides
    Chemical Substances Succinimides ; NAD (0U46U6E8UK) ; Niacinamide (25X51I8RD4) ; Hydrogen (7YNJ3PO35Z) ; Oxidoreductases (EC 1.-) ; Hydrogenase (EC 1.12.7.2) ; N-ethylsuccinimide (MC084H847A) ; Ethylmaleimide (O3C74ACM9V)
    Language English
    Publishing date 2022-09-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 1472881-3
    ISSN 1364-548X ; 1359-7345 ; 0009-241X
    ISSN (online) 1364-548X
    ISSN 1359-7345 ; 0009-241X
    DOI 10.1039/d2cc02411j
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson's Disease.

    Gibson, Lucy L / Pollak, Thomas A / Heslegrave, Amanda / Hye, Abdul / Batzu, Lucia / Rota, Silvia / Trivedi, Dhaval / Nicholson, Timothy R / Ffytche, Dominic / Zetterberg, Henrik / Chaudhuri, K Ray / Aarsland, Dag

    Journal of Parkinson's disease

    2022  Volume 12, Issue 5, Page(s) 1527–1538

    Abstract: ... PD), but their etiology is poorly understood. Plasma neurofilament light (NfL) and p-tau181 are ... between plasma NfL and p-tau181 with the affective and psychotic symptoms in PD.: Methods: We assessed ... the baseline concentration of plasma NfL and p-tau181 in a cohort of 108 patients with PD and 38 healthy ...

    Abstract Background: Neuropsychiatric symptoms are common and important to people with Parkinson's disease (PD), but their etiology is poorly understood. Plasma neurofilament light (NfL) and p-tau181 are biomarkers of neuro-axonal degeneration and tau pathology respectively, which have yet to be explored in association with the affective and psychotic symptoms in PD.
    Objective: To investigate the relationship between plasma NfL and p-tau181 with the affective and psychotic symptoms in PD.
    Methods: We assessed the baseline concentration of plasma NfL and p-tau181 in a cohort of 108 patients with PD and 38 healthy controls. A subgroup of patients (n = 63) were assessed annually with clinical measures for up to 7 years. Psychotic symptoms were assessed using the Non-Motor Symptom Scale and affective symptoms were measured in the Hospital Anxiety and Depression Scale.
    Results: Baseline plasma NfL was a significant predictor of psychotic symptoms longitudinally across the study adjusted for age, Hoehn and Yahr stage, duration of follow up, duration of disease, baseline levodopa and dopamine agonist medication, and baseline cognition: (OR 8.15 [95% CI 1.40-47.4], p = 0.020). There was no association between NfL concentration and the cumulative prevalence of affective symptoms. Plasma p-tau181 concentration was not associated with psychotic or affective symptoms.
    Conclusion: These findings suggest psychotic symptoms are associated with greater neurodegeneration in PD. Further studies are needed to explore NfL as a potential biomarker for psychosis in PD.
    MeSH term(s) Biomarkers ; Humans ; Intermediate Filaments ; Neurofilament Proteins ; Parkinson Disease/diagnosis ; Psychotic Disorders/etiology
    Chemical Substances Biomarkers ; Neurofilament Proteins
    Language English
    Publishing date 2022-04-25
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2620609-2
    ISSN 1877-718X ; 1877-7171
    ISSN (online) 1877-718X
    ISSN 1877-7171
    DOI 10.3233/JPD-223182
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A Longitudinal RCT of P-ESDM With and Without Parental Mindfulness Based Stress Reduction: Impact on Child Outcomes.

    Weitlauf, Amy S / Broderick, Neill / Alacia Stainbrook, J / Slaughter, James C / Taylor, Julie Lounds / Herrington, Catherine G / Nicholson, Amy G / Santulli, Madeline / Dorris, Kristin / Garrett, LaTamara Jackson / Hopton, Michelle / Kinsman, Amy / Morton, Mary / Vogel, Ashley / Dykens, Elisabeth M / Pablo Juárez, A / Warren, Zachary E

    Journal of autism and developmental disorders

    2022  Volume 52, Issue 12, Page(s) 5403–5413

    Abstract: ... in conjunction with the Parent-implemented Early Start Denver Model (P-ESDM). A previous report described ... This manuscript examines child outcomes. 63 children with ASD (< 36 months) and their parents received 12 P-ESDM ...

    Abstract This randomized controlled trial (NCT03889821) examined Mindfulness Based Stress Reduction (MBSR) in conjunction with the Parent-implemented Early Start Denver Model (P-ESDM). A previous report described improved metrics of parental distress (Weitlauf et al. in Pediatrics 145(Supplement 1):S81-S92, 2020). This manuscript examines child outcomes. 63 children with ASD (< 36 months) and their parents received 12 P-ESDM sessions. Half of parents also received MBSR. Longitudinal examination of whole sample means revealed modest improvements in autism severity, cognitive, and adaptive skills. There was not a significant time × group interaction for children whose parents received MBSR. Future work should examine more proximal markers of child or dyadic change to enhance understanding of the impact of providing direct treatment for parents as part of early intervention initiatives.
    MeSH term(s) Child ; Humans ; Autism Spectrum Disorder/diagnosis ; Mindfulness ; Parents/psychology ; Early Intervention, Educational ; Autistic Disorder/therapy
    Language English
    Publishing date 2022-01-18
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 391999-7
    ISSN 1573-3432 ; 0162-3257
    ISSN (online) 1573-3432
    ISSN 0162-3257
    DOI 10.1007/s10803-021-05399-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: A hydrogen-driven biocatalytic approach to recycling synthetic analogues of NAD(P)H

    Reeve, Holly A. / Nicholson, Jake / Altaf, Farieha / Lonsdale, Thomas H. / Preissler, Janina / Lauterbach, Lars / Lenz, Oliver / Leimkühler, Silke / Hollmann, Frank / Paul, Caroline E. / Vincent, Kylie A.

    Chemical communications. 2022 Sept. 20, v. 58, no. 75

    2022  

    Abstract: We demonstrate a recycling system for synthetic nicotinamide cofactor analogues using a soluble hydrogenase with turnover number of >1000 for reduction of the cofactor analogues by H₂. Coupling this system to an ene reductase, we show quantitative ... ...

    Abstract We demonstrate a recycling system for synthetic nicotinamide cofactor analogues using a soluble hydrogenase with turnover number of >1000 for reduction of the cofactor analogues by H₂. Coupling this system to an ene reductase, we show quantitative conversion of N-ethylmaleimide to N-ethylsuccinimide. The biocatalyst system retained >50% activity after 7 h.
    Keywords biocatalysts ; nicotinamide ; oxidoreductases
    Language English
    Dates of publication 2022-0920
    Size p. 10540-10543.
    Publishing place The Royal Society of Chemistry
    Document type Article
    ZDB-ID 1472881-3
    ISSN 1364-548X ; 1359-7345 ; 0009-241X
    ISSN (online) 1364-548X
    ISSN 1359-7345 ; 0009-241X
    DOI 10.1039/d2cc02411j
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Correction: Validation of the use of p-aminobenzoic acid to determine completeness of 24 h urine collections in surveys of diet and nutrition.

    Cox, Lorna / Guberg, Kate / Young, Stephen / Nicholson, Sonja / Steer, Toni / Prentice, Ann / Page, Polly

    European journal of clinical nutrition

    2019  Volume 74, Issue 1, Page(s) 209

    Abstract: Since publication of the original paper, the authors realised that the units of measurement in Table 1 were incorrect. These were changed from "(mg/l)" to "(% dose excreted)". Furthermore a minor typo in the title of the article was also corrected. These ...

    Abstract Since publication of the original paper, the authors realised that the units of measurement in Table 1 were incorrect. These were changed from "(mg/l)" to "(% dose excreted)". Furthermore a minor typo in the title of the article was also corrected. These changes are now present in the HTML and PDF versions of the paper.
    Keywords covid19
    Language English
    Publishing date 2019-10-14
    Publishing country England
    Document type Published Erratum
    ZDB-ID 639358-5
    ISSN 1476-5640 ; 0954-3007
    ISSN (online) 1476-5640
    ISSN 0954-3007
    DOI 10.1038/s41430-019-0515-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux.

    Nicholson, Rachael / Menezes, Ana Catarina / Azevedo, Aleksandra / Leckenby, Adam / Davies, Sara / Seedhouse, Claire / Gilkes, Amanda / Knapper, Steve / Tonks, Alex / Darley, Richard L

    Frontiers in oncology

    2022  Volume 12, Page(s) 840046

    Abstract: ... the expression of the efflux pump, P-GP (ABCB1), and that drug efflux mediated by this transporter fully ... samples also showed a link between PKCϵ and P-GP protein expression suggesting that PKCϵ expression drives ... treatment resistance in AML by upregulating P-GP expression. ...

    Abstract The protein kinase C (PKC) family of serine/threonine kinases are pleiotropic signaling regulators and are implicated in hematopoietic signaling and development. Only one isoform however, PKCϵ, has oncogenic properties in solid cancers where it is associated with poor outcomes. Here we show that PKCϵ protein is significantly overexpressed in acute myeloid leukemia (AML; 37% of patients). In addition, PKCϵ expression in AML was associated with a significant reduction in complete remission induction and disease-free survival. Examination of the functional consequences of PKCϵ overexpression in normal human hematopoiesis, showed that PKCϵ promotes myeloid differentiation, particularly of the monocytic lineage, and decreased colony formation, suggesting that PKCϵ does not act as an oncogene in hematopoietic cells. Rather, in AML cell lines, PKCϵ overexpression selectively conferred resistance to the chemotherapeutic agent, daunorubicin, by reducing intracellular concentrations of this agent. Mechanistic analysis showed that PKCϵ promoted the expression of the efflux pump, P-GP (ABCB1), and that drug efflux mediated by this transporter fully accounted for the daunorubicin resistance associated with PKCϵ overexpression. Analysis of AML patient samples also showed a link between PKCϵ and P-GP protein expression suggesting that PKCϵ expression drives treatment resistance in AML by upregulating P-GP expression.
    Language English
    Publishing date 2022-05-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2022.840046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Validation of the use of p-aminobenzoic acid to determine completeness of 24 h urine collections in surveys of diet and nutrition.

    Cox, Lorna / Guberg, Kate / Young, Stephen / Nicholson, Sonja / Steer, Toni / Prentice, Ann / Page, Polly

    European journal of clinical nutrition

    2018  Volume 72, Issue 8, Page(s) 1180–1182

    Abstract: ... are complete. This can be validated by monitoring urinary excretion of p-aminobenzoic acid (PABA ...

    Abstract Sodium intake is assessed using 24 h urinary excretion; it is important to ensure urine collections are complete. This can be validated by monitoring urinary excretion of p-aminobenzoic acid (PABA) administered in tablet form at intervals during the urine collection. Unavoidable change of PABA tablet supplier and analytical procedure required re-establishment of the thresholds consistent with a complete collection. Reference ranges for adults without reported intestinal or renal disease were determined by HPLC (70-103%) and colorimetry (84-120%). Some individuals excreted a small, measurable amount of PABA the following day but this did not represent the balance of the PABA ingested. Assay of the PABA tablets confirmed the stated dose (80 mg) and demonstrated their stability up to 8 years (duration of study) at room temperature. These tablets have been used and the reference ranges applied in UK national population surveys since 2008.
    MeSH term(s) 4-Aminobenzoic Acid/urine ; Adult ; Chromatography, High Pressure Liquid ; Colorimetry ; Diet Surveys/methods ; Drug Stability ; Female ; Humans ; Male ; Middle Aged ; Nutrition Surveys/methods ; Reference Values ; United Kingdom ; Urine Specimen Collection/methods ; Urine Specimen Collection/standards
    Chemical Substances 4-Aminobenzoic Acid (TL2TJE8QTX)
    Language English
    Publishing date 2018-06-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Validation Study
    ZDB-ID 639358-5
    ISSN 1476-5640 ; 0954-3007
    ISSN (online) 1476-5640
    ISSN 0954-3007
    DOI 10.1038/s41430-018-0195-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Molecular Cloning and Functional Analysis of Gene Clusters for the Biosynthesis of Indole-Diterpenes in Penicillium crustosum and P. janthinellum.

    Nicholson, Matthew J / Eaton, Carla J / Stärkel, Cornelia / Tapper, Brian A / Cox, Murray P / Scott, Barry

    Toxins

    2015  Volume 7, Issue 8, Page(s) 2701–2722

    Abstract: ... synthesized by Penicillium crustosum and P. janthinellum. Using a combination of PCR, cosmid library screening ... of these compounds. Targeted deletion of penP in P. crustosum abolished the synthesis of penitrems A, B, D, E, and F ... and led to accumulation of paspaline, a key intermediate for paxilline biosynthesis in P. paxilli ...

    Abstract The penitremane and janthitremane families of indole-diterpenes are abundant natural products synthesized by Penicillium crustosum and P. janthinellum. Using a combination of PCR, cosmid library screening, and Illumina sequencing we have identified gene clusters encoding enzymes for the synthesis of these compounds. Targeted deletion of penP in P. crustosum abolished the synthesis of penitrems A, B, D, E, and F, and led to accumulation of paspaline, a key intermediate for paxilline biosynthesis in P. paxilli. Similarly, deletion of janP and janD in P. janthinellum abolished the synthesis of prenyl-elaborated indole-diterpenes, and led to accumulation in the latter of 13-desoxypaxilline, a key intermediate for the synthesis of the structurally related aflatremanes synthesized by Aspergillus flavus. This study helps resolve the genetic basis for the complexity of indole-diterpene natural products found within the Penicillium and Aspergillus species. All indole-diterpene gene clusters identified to date have a core set of genes for the synthesis of paspaline and a suite of genes encoding multi-functional cytochrome P450 monooxygenases, FAD dependent monooxygenases, and prenyl transferases that catalyse various regio- and stereo- specific oxidations that give rise to the diversity of indole-diterpene products synthesized by this group of fungi.
    MeSH term(s) Base Sequence ; Cloning, Molecular ; DNA, Fungal/analysis ; Diterpenes/metabolism ; Fungal Proteins/genetics ; Genes, Fungal ; Indoles/metabolism ; Molecular Sequence Data ; Multigene Family ; Mycotoxins/metabolism ; Oxygenases/genetics ; Penicillium/genetics ; Penicillium/metabolism ; Sequence Analysis, DNA ; Transferases/genetics
    Chemical Substances DNA, Fungal ; Diterpenes ; Fungal Proteins ; Indoles ; Mycotoxins ; indole (8724FJW4M5) ; Oxygenases (EC 1.13.-) ; Transferases (EC 2.-)
    Language English
    Publishing date 2015-07-23
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518395-3
    ISSN 2072-6651 ; 2072-6651
    ISSN (online) 2072-6651
    ISSN 2072-6651
    DOI 10.3390/toxins7082701
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Energy metabolism and mitochondrial defects in X-linked Charcot-Marie-Tooth (CMTX6) iPSC-derived motor neurons with the p.R158H PDK3 mutation.

    Perez-Siles, G / Cutrupi, A / Ellis, M / Screnci, R / Mao, D / Uesugi, M / Yiu, Eppie M / Ryan, Monique M / Choi, B O / Nicholson, G / Kennerson, M L

    Scientific reports

    2020  Volume 10, Issue 1, Page(s) 9262

    Abstract: ... characterised by length dependent degeneration of axons of the peripheral nervous system. A missense mutation (p ... critically linking glycolysis and the energy producing Krebs cycle. We had shown the p.R158H mutation causes ...

    Abstract Charcot-Marie-Tooth (CMT) is a group of inherited diseases clinically and genetically heterogenous, characterised by length dependent degeneration of axons of the peripheral nervous system. A missense mutation (p.R158H) in the pyruvate dehydrogenase kinase 3 gene (PDK3) has been identified as the genetic cause for an X-linked form of CMT (CMTX6) in two unrelated families. PDK3 is one of four PDK isoenzymes that regulate the activity of the pyruvate dehydrogenase complex (PDC). The balance between kinases (PDKs) and phosphatases (PDPs) determines the extend of oxidative decarboxylation of pyruvate to generate acetyl CoA, critically linking glycolysis and the energy producing Krebs cycle. We had shown the p.R158H mutation causes hyperactivity of PDK3 and CMTX6 fibroblasts show hyperphosphorylation of PDC, leading to reduced PDC activity and ATP production. In this manuscript we have generated induced pluripotent stem cells (iPSCs) by re-programming CMTX6 fibroblasts (iPSC
    MeSH term(s) Adenosine Triphosphate/metabolism ; Base Sequence ; Cell Differentiation/genetics ; Charcot-Marie-Tooth Disease/genetics ; Charcot-Marie-Tooth Disease/pathology ; Energy Metabolism/genetics ; Fibroblasts/pathology ; Humans ; Induced Pluripotent Stem Cells/cytology ; Mitochondria/pathology ; Motor Neurons/pathology ; Mutation ; Phosphorylation ; Pyruvate Dehydrogenase Acetyl-Transferring Kinase/genetics
    Chemical Substances PDK3 protein, human ; Pyruvate Dehydrogenase Acetyl-Transferring Kinase ; Adenosine Triphosphate (8L70Q75FXE)
    Language English
    Publishing date 2020-06-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-020-66266-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top